| Drug Name | Pathway ID | Pathway name | P-value | No. of gene members | UniProt AC | Gene name | Detail of Coexpression | |
|---|
| Chloramphenicol | hsa00340 | Histidine metabolism | 4.52E-02 | 1 | O95954 | FTCD | More | | | Chloramphenicol | hsa00564 | Glycerophospholipid metabolism | 9.70E-03 | 2 | Q9Y259, P49619 | CHKB, DGKG | More | | | Chloramphenicol | hsa01100 | Metabolic pathways | 2.25E-02 | 7 | Q9Y259, Q13956, P49619, O95954, Q02318, Q9UBX8, P35573 | CHKB, PDE6H, DGKG, FTCD, CYP27A1, B4GALT6, AGL | More | | | Chloramphenicol | hsa03320 | PPAR signaling pathway | 1.62E-02 | 2 | Q13133, Q02318 | NR1H3, CYP27A1 | More | | | Chloramphenicol | hsa04110 | Cell cycle | 3.57E-02 | 3 | Q9UBD5, P06493, P33981 | ORC3, CDK1, TTK | More | | | Chloramphenicol | hsa05145 | Toxoplasmosis | 3.96E-02 | 2 | P28068, Q16787 | HLA-DMB, LAMA3 | More | | | Chloramphenicol | hsa05165 | Human papillomavirus infection | 2.01E-02 | 3 | Q16787, Q02930, Q13315 | LAMA3, CREB5, ATM | More | | | Chloramphenicol | hsa05166 | Human T-cell leukemia virus 1 infection | 2.91E-02 | 3 | Q02930, P28068, Q13315 | CREB5, HLA-DMB, ATM | More | | | Chloramphenicol | hsa05231 | Choline metabolism in cancer | 2.00E-02 | 2 | Q9Y259, P49619 | CHKB, DGKG | More | |
|
